Innovative Models in the Rehabilitation of the Elderly With Hip Fractures Through Technological Innovation

Launched by ISTITUTO NAZIONALE DI RICOVERO E CURA PER ANZIANI · Sep 18, 2019

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to help elderly patients recover from hip fractures using a robotic device. The goal is to improve rehabilitation outcomes not just right after treatment, but also over the long term, with participants being followed up three times after the initial rehabilitation. The researchers want to see if this innovative technology can make a real difference in how well older adults heal and regain their strength after such injuries.

To be eligible for this trial, participants need to be able to give their consent and have experienced a hip fracture within the last 60 days. They should also have some difficulty with walking, as indicated by specific tests. However, those with certain health issues, like severe neurological diseases or conditions that prevent them from standing or walking, won’t be able to participate. If you or a loved one joins the trial, you can expect to receive rehabilitation using the robotic device, along with regular check-ins to monitor progress. This is an exciting opportunity to be part of a study that could change how we help older adults recover from hip fractures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Capacity to consent
• • Traumatic event within 60 days
• • Romberg test: negative
• • Functional Ambulation Category (FAC) score ≤ 2
• • Ranking scale score ≤ 3;
• Exclusion Criteria:
• • Past history of syncopal episodes
• • Presence of non-pharmacologically compensated behavioral syndromes
• • Presence of pain that prevents walking or standing
• • Presence of neurological pathologies that compromise balance (Multiple sclerosis, Parkinson's disease, stroke, ataxias, poliomyelitis)
• • Spinal stenosis
• • Radiculopathy
• • Neuropathies lower limbs
• • Disabling disabilities that impair walking (eg congenital malformations of the foot)
• • Heterometry \> 2 cm
• • Clinical dementia rating (CDR) score ≥ 3
• • Severe systemic diseases with life expectancy \< 1 year
• • Patients unable to follow up.